Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Gastroenterology Clinics of North America|July 31, 2026
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile InfectionSalam P Bachour, Ari GrinspanCurrent Gastroenterology Reports|January 16, 2024
Clinical Update on the Prevention and Management of Postoperative Crohn's Disease RecurrenceSalam P Bachour, Benjamin H ClickGastroenterology & Hepatology|August 6, 2016
Fecal Microbiota Transplantation for Inflammatory Bowel DiseaseJoanna Lopez, Ari GrinspanCurrent Gastroenterology Reports|July 6, 2015
Positioning Therapy for Ulcerative ColitisAri Grinspan, Asher KornbluthTherapeutic Advances in Gastroenterology|April 24, 2023
The impact of the COVID-19 pandemic on Clostridioides difficile infection and utilization of fecal microbiota transplantationSalam P Bachour, Rahul Dalal, Jessica R AllegrettiDigestive Diseases and Sciences|January 9, 2022
Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised CohortKelly Suchman, Yuying Luo, Ari GrinspanJournal of Clinical Gastroenterology|January 20, 2021
Oral Fecal Microbiota Transplant Capsules Are Safe and Effective for Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-AnalysisCharles Du, Yuying Luo, Samantha Walsh, et al.Intestinal Failure (New York, N.Y.)|February 6, 2026
Safe and successful fecal microbiota transplantation for recurrent Clostridioides difficile infection in a child with an intestinal transplantJuliana Kennedy, Kishore Iyer, Ari Grinspan, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2019
Patients Eligible for Trials of Microbe-Based Therapeutics Do Not Represent the Population With Recurrent Clostridioides difficile InfectionColleen R Kelly, Monika Fischer, Ari Grinspan, et al.Journal of Digestive Diseases|October 2, 2022
Fecal microbiota transplantation may reduce the mortality of patients with severe and fulminant Clostridioides difficile infection compared to standard-of-care antibiotics in a community hospitalMaria Mironova, Adam C Ehrlich, Ari Grinspan, et al.Pageof 5